1. HBW Insight
  2. >>Ingredients & Safety

PCPC Exploring Alternate Approach For Meeting California Air Quality Goals

 
• By Lauren Nardella

By shifting to less reactive VOCs, the personal-care industry could reduce its contribution to ground-level ozone without sacrificing product efficacy, which stakeholders say is a virtual certainty under mass VOC reductions proposed in November by the California Air Resources Board.

Vector artistic pen and ink drawing illustration of smoke coming from house chimney into air. Environmental concept of VOC or volatile organic compound pollution. - Vector

The Personal Care Products Council is in discussions with the California Air Resources Board about an alternate approach to reducing cosmetics products’ ozone impacts without cutting volatile organic compounds (VOCs) to levels that would compromise product functionality.

The trade group could follow the lead of other sectors that have worked with the CARB to develop a maximum...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

AESGP Annual Meeting: Harmonizing EU VMS Max Levels Could Cost Sector Over €200m

 
• By David Ridley

Limited capacity and a two-to-three year timescale for reformulation could mean that many VMS supplements disappear from the market, warns EPPA partner Alexandra Bocquillion, speaking at the AESGP Annual Meeting in Warsaw, Poland.

EU Pharma Reform: Council Proposes Rx Exemption For Topical Antimicrobials

 
• By David Ridley

The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”

Review Suggests Advantage Of Bayer’s Iberogast Advance For Digestive Disorders

 
• By David Ridley

Bayer's Iberogast Advance's combination of six herbal ingredients may produce a synergistic effect that acts on multiple underlying issues contributing to digestive disorders like functional dyspepsia (FD) and irritable bowel syndrome (IBS), a recently published study suggests.

Allergy Ingredient Itch Warning, ACNU Final Rule Scratch Extent Of FDA Authority For Label Changes

 
• By Malcolm Spicer

Effective date for ACNU OTC switch final rule and finding of severe itching from long-term use of common allergy ingredients are bookends for limits of FDA’s authority for product label changes.

More from HBW Insight

US FDA May Consolidate Support Services After Extensive Cuts

 
• By Derrick Gingery and Sue Sutter

Commissioner Martin Makary told staff that plans are being developed to centralize HR, IT, travel and other functions, which were heavily impacted by the 1 April reduction-in-force.

US FDA Clarifies Success For An NDI Notification Fits Only The Notifier’s Ingredient

Along with two instructional videos, FDA provides fact sheet detailing common problems with NDINs while supplement industry awaits guidance on two hurdles for clearing the NDIN process, providing identity information and evidence of safety for ingredients.

EPR Alert! Unregistered Producers In Colorado No Longer Permitted To Sell 1 July

 
• By Eileen Francis

Packaging producers subject to Colorado’s Extended Producer Responsibility program that have not registered with the organization running the program will no longer be able to sell in the state starting 1 July.